MD Anderson News Release 12/19/13
New reality for long-time dream of medical researchers is grounded in work by Jim Allison
Detect. Destroy. Remember. The mantra of the immune system’s relentless campaign against infectious invaders and the body’s own abnormal cells finally is applying to cancer in meaningful ways.
The journal Science today named cancer immunotherapy its 2013 Breakthrough of the Year, the...
MD Anderson News Release 12/16/13
After working together for more than 23 years to accomplish their joint goal of raising the quality...
Discoveries in T cell biology, development of immune checkpoint blockade cancer therapy honored
MD Anderson News Release...
MD Anderson News Release 12/12/13
Abstract #P3-06-02
Listen to Podcast
More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures – including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis, according to research from The University of Texas MD Anderson Cancer...
Combination therapy sparks complete responses in 52 percent of patients in clinical trial
MD Anderson News Release 12/...
Gordon Mills, M.D., Ph.D., professor and chair of Systems Biology at The University of Texas MD Anderson Cancer Center, will...
Proportion of patients reporting good quality of life goes from 46 to 89 percent in six months
MD Anderson News Release...
Disease progression halted in 76 percent of patients at 30 months, side effects decline
MD Anderson News Release 12/09/...
First-in-human application of T cells modified by “awakened” DNA sequence system reveals no toxicities from treatment after...
PKM2 controls mitosis, saving cancer cells from death and promoting brain tumor growth
MD Anderson News Release...